Make Your Laboratories More Efficient, and More Profitable
With thousands of UPLC systems and UPLC columns delivered worldwide, see why the world's top-branded companies and institutions have standardized on ACQUITY UPLC: the fastest-growing new LC platform in the market for five years running.
"We're always looking to improve quality and efficiency in our group, and UPLC® answered this for us. Waters has a reputation for being the gold standard of high-pressure chromatography." - Powell K., Enthalpy Analytical, Inc.
To satisfy their customers' fundamental need for faster, high-quality laboratory results, one analytical services organization selected the Waters ACQUITY UPLC® System - it also matched the company's overall streamlining efforts.
As many pharmaceutical companies strive to shorten drug development time by using contract laboratories, these organizations are increasingly relied upon for not only their analytical expertise, but also for offering far greater efficiencies at a lower cost. With a robust laboratory workflow, it's easy to stand out from competitors.
Eliminate analytical work backlogs and slow turnaround times
Increase laboratory flexibility, quality, and efficiency
Assure capacity ahead of increasing demand, and can commit to meet deadlines consistently
CONTACT: www.waters.com
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Pfizer, GSK Gain ACIP Recommendations for RSV and Meningococcal Vaccines
April 18th 2025The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted to expand access to Pfizer’s respiratory syncytial virus vaccine Abrysvo for high-risk adults in their 50s and voted in favor of GSK’s meningococcal vaccine, Penmenvy, for streamlined adolescent protection.
